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Abstract
Background: The middle ear of mammals is composed of three endochondrial ossicles, the
stapes, incus and malleus. Joints link the malleus to the incus and the incus to the stapes. In the
mouse the first arch derived malleus and incus are formed from a single Sox9 and Type II collagen
expressing condensation that later subdivides to give rise to two separate ossicles. In contrast the
stapes forms from a separate condensation derived from the second branchial arch. Fusion of the
malleus and incus is observed in a number of human syndromes and results in conductive hearing
loss. Understanding how this joint forms during normal development is thus an important step in
furthering our understanding of such defects.
Results: We show that the developing incudomalleal joint is characterised by a lack of proliferation
and discrete areas of apoptosis. Apoptosis has been suggested to aid in the removal of pre-
cartilaginous cells from the joint region, allowing for the physical separation of the cartilaginous
elements, however, we show that joint initiation is unaffected by blocking apoptosis. There is also
no evidence of cell migration out of the presumptive joint region, as observed by labelling of joint
and ossicle cells in culture. Using Type II collagen lacZ reporter mice, however, it is evident that cells
in the presumptive joint region remain in place and downregulate cartilage markers.
Conclusion: The malleus and incus first appear as a single united condensation expressing early
cartilage markers. The incudomalleal joint region forms by cells in the presumptive joint region
switching off cartilage markers and turning on joint markers. Failure in this process may result in
fusion of this joint, as observed in human syndromes such as Branchio-Oto-Renal Syndrome or
Treacher Collins Syndrome.
Background
In the mouse the malleus and incus of the middle ear ini-
tially develop as a single element that expresses cartilage
markers such as Type II collagen and Sox9. This united
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by the incudomalleal joint [1,2]. This early joint region is
free of Type II collagen or Sox9 expressing cells and
expresses joint markers such as Gdf5 [1]. Sox9 has been
shown to upregulate Type II collagen expression, and over-
expression of Sox9 leads to ectopic cartilage formation
[3,4]. Loss of Sox9 and Type II collagen, therefore, is
thought to play an important role in formation of the
joint.
The formation of three ossicles in the middle ear (malleus,
incus and stapes) is a characteristic of mammals. During
the course of evolution the primary jaw articulation of
non-mammalian vertebrates was replaced by a second
articulation between two membranous bones, the squa-
mosal and dentary [5]. Studies involving comparative
anatomy, embryology and paleontology have suggested
that the primary jaw articulation, along with the hyoman-
dibular (columella in chick and reptiles) were incorpo-
rated into the middle ear to form a three ossicle chain.
Using this criteria, the malleus is homologous to the artic-
ular part of Meckel's cartilage, the incus is homologous to
the quadrate/palatoquadrate, and the stapes is homolo-
gous to the hypomandibular [5,6]. The incudomalleal
joint is therefore homologous to the primary jaw joint.
Homology has been confirmed by investigating expres-
sion of genes such as Bapx1 (Nkx3.2), which is specifically
expressed in the primary jaw joint of Xenopus, zebrafish
and chick and in the incudomalleal joint in mammals [7-
10]. Like the incudomalleal joint, the primary jaw joint
divides two initially continuous elements expressing Type
II collagen, the quadrate and articular part of Meckel's car-
tilage [9]. These two cartilages then separate to form the
articulation point for the upper and lower jaws.
In a variety of human syndromes, such as Treacher Collins
and Branchio-Oto-Renal (BOR) syndrome, the malleus
and incus are often fused resulting in conductive hearing
loss [11-14]. The development of this joint is therefore
essential to ensure correct hearing. It is thus of interest to
examine what happens to these presumptive joint cells
that are initially fated to become cartilage.
In a variety of limb joints, apoptosis has been observed
within the interzone at the centre of the developing joint
[15]. Such programmed cell death was postulated to
account for the loss of the cartilage lineage cells within the
forming joint, leading to the separation of skeletal ele-
ments [16-20]. Given this data from the limb, we wished
to investigate the role of apoptosis in early joint formation
in the middle ear.
Apoptosis can be mediated by distinct pathways initiating
from within (intrinsic) or outside (extrinsic) the cell. Both
pathways involve signalling via a family of cysteine pro-
teases named caspases [21]. Caspase machinery becomes
activated in a cascade manner starting with apical cas-
pases, such as Caspase 8 and Caspase 9, leading to cleav-
age of effector caspases, such as Caspase 3. Caspase 8
mutants die at E11.5 due to cardiovascular abnormalities
[22], but Caspase 9 and Caspase 3 mutant mice survive up
to and past birth depending on the strain [23-26]. These
mutants display a strikingly similar phenotype, character-
ised by a prominent brain malformation caused by defec-
tive apoptosis in the proliferative neuroepithelium
[25,26]. Caspase 9 is activated within a complex known as
the apoptosome, where the pro-caspase 9 interacts with
Cytochrome c and Apaf-1 [27]. Cytochrome c deficient
mice die at E8.5 [28], however the majority of Apaf-1
mutant mice survive up to E18.5. These mice exhibit
defects in the brain, inner ear and digits [29-31]. The mid-
dle ear can therefore be analysed in Apaf-1, Caspase 3, and
Caspase 9 mutant mice.
To knock down activation of all caspases, an in vitro
approach must be applied and pharmacological inhibi-
tors binding to the active site of activated caspases are gen-
erally used [32]. We have therefore devised a method for
culturing the middle ear in the presence or absence of cas-
pase activity. By these two methods the role of apoptosis
in formation of the incudomalleal joint can be analysed.
In the digits, developing cartilage recruits neighbouring
cells into the cartilage creating high cell density in these
regions [33]. It was therefore possible that the Sox9/Type II
collagen expressing cells in the presumptive joint might
migrate out of the forming joint into the body of the mal-
leus or incus. To test this we labelled cells in the forming
incudomalleal joint region and developing malleus with
the lipophilic dyes DiO and DiI, and observed the move-
ments of labelled cells as the joint formed in culture.
Alternatively, the Sox9/Type II collagen positive cells might
remain in position and downregulate expression of these
genes. To investigate this possibility we have utilised Type
II collagen lacZ reporter mice, where the stable lacZ protein
marks cells that express Type II collagen and also those that
have recently switched off Type II collagen.
By these methods we hope to determine what processes
are involved in early joint development in the middle ear.
Methods
Animals
Wild type and Type II collagen LacZ reporter mouse
embryos were dissected out at embryonic day (E) 13.5 to
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Lakhani (Howard Hughes Medical Institute, Yale Univer-
sity School of Medicine, New Haven, USA).
Caspase 9/C57BI/6J mutant mice were provide by Prof.
K.A. Roth (Department of Neuropathology, University of
Alabama, USA).
Apaf-1 mutant mice were generated as described in [31].
All research on animals follows internationally recog-
nized guidelines. Use of genetically modified organisms
was approved by the local Genetic Modification Safety
Committee (GMSC).
Middle ear explant culture system
Middle ear regions were dissected from the lateral parts of
mouse embryonic heads, and placed on Millipore filters
supported on metal grids over medium using a modified
Trowell method [34]. Culture medium consisted of
DMEM (Sigma) supplemented with glutamine, pen/strep
and 10% fetal calf serum. Fresh medium was delivered
every 24 h and cultures were kept at 37°C, 5% CO2 for up
to 4 days.
Caspase inhibition
The pharmaceutical inhibitor of general caspase Z-VAD-
FMK (R&D Systems) was dissolved in ACS DMSO (Sigma
Aldrich) and added to the fresh culture medium at a final
concentration of 200 µM. Control medium was supple-
mented by 1%DMSO corresponding to the amount of
DMSO in the inhibitor solution, as has been used in pre-
vious publications [35]. Culture medium was changed
every day for 3 days.
Biotinylated pan caspase inhibitor (R&D Systems) was
exploited to check the distribution of the inhibitor
throughout the explant. The pan caspase inhibitor was
applied in the same way as the general one and its distri-
bution was traced in histological sections after addition of
streptavidin-AP (BD Biosciences) and NBT/BCIP colour
reaction, showing successful spread of the inhibitor (data
not shown).
The effect of the inhibitor on apoptosis was tested in
developing limbs where the interdigital tissue is known to
disappear by caspase dependent apoptosis [36]. Front
limbs from E12.5 mouse embryos were cultured simulta-
neously and in the same way as the middle ear cultures for
24–72 hours. Formation of digits and interdigital space
was documented microscopically.
Staining
Embryos were fixed in 4% paraformaldehyde and dehy-
drated to 100% ethanol. Paraffin wax sections were cut at
8 µm and split over 5 to 6 slides. Serial sections were
stained with hematoxylin/eosin to visualize the early tis-
sue morphology or with Sirrus red and Alcian blue to view
the developing bones and cartilage.
Type II collagen LacZ reporter mice were fixed and stained
with β galactosidase in wholemount as described in [37].
Proliferation assays
PCNA (proliferating cell nuclear antigen)
A polyclonal PCNA antibody (Santa Cruz) was applied for
1 hour (room temperature) after pretreatment in 0.01 M
citric buffer (microwave irradiation for 10 mins). Applica-
tion of the secondary antibody (labeled with horse radish
peroxidase – HRP) for 30 mins was followed by a colour
reaction using 3',3 '-diaminobensidine (DAB) as the sub-
strate.
Anti-phosphohistone H3 immunohistochemistry
Embryos were fixed in 5% acetic acid in ethanol overnight
at 4°C, dehydrated through a graded series of ethanol,
embedded in paraffin wax and sectioned. Sections were
processed for antibody staining using rabbit anti-phos-
phorylated histone 3 (1:200 dilution, Upstate Biotechnol-
ogy, Lake Placid, NY) as described previously [38]. The
antibody targets were visualized with Alexa-fluor 568-
goat-anti-rabbit-IgG (1:500 dilution, Molecular probes,
Leiden, the Netherlands). Slides were mounted in Slow-
fade Gold antifade reagent with DAPI (Molecular Probes)
according to manufacturers instructions and visualized by
fluorescence microscopy (Carl Zeiss, New York).
Apoptosis evaluation
TUNEL assay
An ApopTag Peroxidase In Situ Apoptosis Detection Kit
was used to detect apoptotic DNA breaks in individual
cells (Chemicon). For the Colour reaction a DAB Sub-
strate Kit was used, with Nickel staining to give a black col-
our (Vector Labs). Eosin was used for counterstaining of
the sections.
Morphological criteria
Nuclear condensations and formation of apoptotic bodies
were evaluated additionally to the TUNEL test [39].
Cell Labelling
DiI (1,1' dioctadecyl-3, 3,3',3'-tetramethyl-indocarbocya-
nine perchlorate) and DiO (3,3'-dioctadecyloxacarbocya-
nine perchlorate) were used as cell lineage labels. A stock
solution of DiI (Cell tracker- Molecular probes) (0.5%)
was made in 100% ethanol and diluted 1:9 with 0.3 M
sucrose on the day of use. For the DiO labelling, a ready-
made Vybrant DiO cell-labelling solution was used (Invit-
rogen). The Dil solution was injected into the developing
malleus of dissected lower jaws using a mouth pipettePage 3 of 12
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DiO was injected into the presumptive joint region
between the malleus and incus. The cultures were then
moved to explant culture dishes and photographed under
light and dark field. Cultures were left to develop for 48
hours and photographed at 24 hour intervals.
Type II collagen Immunohistochemistry
Type II collagen immunohistochemistry was performed
using 11–116B3 antibody (Developmental Studies Hybri-
doma Bank) on paraffin wax sections. To enhance the sig-
nal, slides were microwaved in 0.01 M citrate buffer [40],
and treated with Chondroitinase ABC at 0.25 U per ml
and Hyaluronidase at 1.45 U per ml at 37°C for 45 min-
utes (Sigma). The collagen antibody was used at a dilution
of 1:100.
Radioactive in situ hybridisation
Radioactive in situs were performed using 35S as described
[41]. Gdf5 probe was linearised with HindIII and tran-
scribed with T7.
Results
Proliferation in the incudomalleal joint
Very few PCNA positive cells have been observed in the
immediate layer of developing joints in the limb [20,42-
44]. The joint region is thus thought of as a region of low
proliferation. To see whether this situation is mimicked in
the middle ear we looked at the distribution of proliferat-
ing cells during early formation of the incudomalleal
joint. At E14.5 and E15.5 the malleus and incus are seen
as separate structures with a clear joint in between. Using
PCNA, the level of proliferation was high in the head of
the malleus and incus but the joint region was negative
(Fig. 1A,B,D,E). PCNA has a long half-life leading to its
continuous expression in cells that are not actively divid-
ing [45]. We, therefore, supplemented our results by using
anti-phosphohistone H3 immunohistochemistry. The H3
antibody detects phosphorylation of histone H3, which is
high during chromosome condensation as the cell enters
the M-phase and has a short half-life. As expected, only a
few cells were observed as positive in the middle ear using
this method compared to using PCNA. The positive cells
were concentrated in and around the ossicles but again
excluded from the developing joint (Fig. 1C,F). Labelled
cells were also located around the circumference of the eye
as previously published using this method, indicating that
the assay was working [38].
At E13.5 the malleus and incus are still continuous [1]. At
this early stage using PCNA, proliferation was observed in
the malleus and incus but the forming joint region was
negative, reflecting the situation observed at later stages
(Fig. 1G,H). Using the H3 antibody at this stage, the incus
showed positive proliferating cells but the presumptive
joint region appeared negative (Fig. 1I). The malleus also
appeared negative, using the antibody to H3, perhaps
indicating a time delay between proliferation of the two
ossicles.
Apoptosis in the incudomalleal joint
A TUNEL assay was performed to detect nuclear DNA frag-
mentation in the developing joint from E13.5 to E15.5.
Additionally, morphological criteria of apoptotic cells
(nuclear condensation, apoptotic bodies) were evaluated.
At E13.75, as the malleus and incus are starting to sepa-
rate, a clear region of apoptotic cells was visible in a whirl
underneath the head of the malleus (N = 4) (Fig. 2A,B). At
E14.5 and E15.5, when the joint is clear histologically, a
few positive cells were located in this same region under
the head of the developing malleus, with a line of positive
cells running between the malleus and the incus (Fig.
2C,D and data not shown) (N = 6). TUNEL positive cells
were also observed in the external auditory meatus and in
the inner ear, where apoptosis has been previously
described, confirming that the method was successful
[30,46] (data not shown).
To investigate the functional significance of these areas of
apoptosis for middle ear development, we investigated
middle ear development in mice where different compo-
nents of the apoptotic machinery had been knocked out,
and used an explant culture system to block the action of
all caspases in this region.
Pro-apoptotic molecules Apaf-1, Caspase 3 and 9 are not 
involved in the initiation of the incudomalleal joint
Mutant mice are a great tool to study the consequences of
a particular apoptotic deficiency in vivo. Apaf-1, Caspase 3
and Caspase 9 mutants were analysed at E15.5 to reveal
any consequences of their deficiency on early develop-
ment of the middle ear joint. These embryos displayed a
variety of craniofacial defects, with a number showing
obvious overgrowth of the brain, as would be expected
from previously published observations [31]. By E15.5
the joint region between the malleus and incus is clearly
visible in section in wildtype mice (Fig. 3A). The malleus
and incus were found completely separated, and no carti-
lage-like cells were evident in the joint in either the
wildtype or mutant embryos (Fig. 3A–C and data not
shown) (Caspase 3 and 9 mutants N = 3; Apaf-1 mutants
N = 4). In order to confirm the absence of apoptosis in
these mutants a TUNEL stain was carried out in the Apaf-
1 mutants. No TUNEL positive cells were observed in the
middle ear region, compared to a heterozygous littermate
or wildtype, thus confirming that apoptosis has been
inhibited in these mutants (Fig. 3D–F). To confirm the
lack of phenotype in the mutants, sections were carried
out on Apaf-1 mutants at E17.5 and E18.5, once the shape
of the articulation is well formed (N = 6). In section thePage 4 of 12
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the articulation showed subtle variations in some speci-
mens while in others it appeared identical to that of a
wildtype littermate (Fig. 4A,B). This difference might
relate to slight variations in the angle of section, rather
than indicate a true defect, and so to confirm the result
skeletal preparations of mutant heads were examined. In
these no obvious defect was observed in the shape of the
articulation and the body of the malleus and incus
appeared normal (Fig. 4C,D) (N = 4). Loss of apoptosis,
therefore, did not appear to disrupt joint formation or
gross joint morphology. To confirm this an in vitro explant
culture approach was introduced to inhibit all caspases in
cultures of the middle ear.
Caspase inhibition in middle ear explant culture
Pharmaceutical inhibitors bind to the active site of acti-
vated caspases and are routinely used to inhibit caspase
activity in vitro [35,36]. For our explant culture we used a
modified method of ex vivo middle ear culture [47]. This
technique allows a clear observation of the middle ear
structures as they develop over several days. In order to
demonstrate the effectiveness of apoptosis inhibition
using the general caspase inhibitor, developing front
Proliferating cells are not observed in the developing joint regionFigure 1
Proliferating cells are not observed in the developing joint region. (A, B, D, E, G, H) PCNA staining of sagittal sec-
tions through the middle ear. Proliferating cells stained brown against a blue background. (C, F, I) Anti-phosphohistone H3 
immunohistochemistry of sagittal sections through the middle ear. Cells outlines by DAPI (blue). Proliferating cells label as 
bright red spots. Ossicles are outlined with white dashes. (A-C) E15.5. (D-F) E14.5. (G-I) E13.5. (A, D) Malleus and incus. Joint 
region marked by *. (B, E) High power view of the joint region, showing no positively stained cells compared to the adjacent 
malleus and incus. (C, F) H3 positive cells are located within and around the ossicles but not in the joint region (*). (G) United 
malleus and incus. Presumptive joint region marked by *. (H) High power view of the malleus and presumptive joint region, 
showing no positively stained cells in the presumptive joint (*) compared to the adjacent malleus. (I) H3 positive cells are 
located within the incus but not in the presumptive joint region (*). M = malleus and I = incus. Scale bars in (A, B, C) = 100 µm.Page 5 of 12
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hours. Interdigital tissue regression was prevented in the
caspase inhibitor samples compared to the controls (Fig.
5A,B) (N = 12).
Middle ears were dissected out at E12.5, several days prior
to any morphological sign of a joint. These were then cul-
tured for 3 days until a clear joint could be observed
between the malleus and incus in control cultures. In cul-
tures treated with the general caspase inhibitor a normal
joint was observed, free from cartilaginous cells (Fig. 5C)
(N = 4).
Cell migration
Utilising the same middle ear explant culture system, we
investigated whether cells in the presumptive joint region
migrated away from the developing interzone and were
recruited into the ossicles. Cultures were set up at E13.5,
before joint initiation. The ossicles and associated middle
ear structures developed well in culture along with neigh-
bouring structures such as the inner ear (data not shown).
Double labelling was used to identify any movement
between cells in the presumptive joint region and the
neighbouring malleus. A single spot of DiO was mouth
pipetted in the region of the presumptive joint and a sec-
ond spot of DiI was placed alongside in the developing
malleus (Fig. 6A-A") (N = 10). The movement of these
Apoptotic cells are located between the malleus and incusFigure 2
Apoptotic cells are located between the malleus and incus. TUNEL staining of middle ear sections in sagittal plane at 
E13.75 (A, B) and E15.5 (C-D). (B, D) High power views of (A, C). (A, B) Positive cells (black) are located under the head of the 
malleus as the joint starts to form. (C-D) Positive cells are located between the malleus and incus. Arrows point to TUNEL 
positive cells. Scale bars in (A, B) 150 µm. M = Malleus. I = Incus.Page 6 of 12
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Over this time period no movement of the DiO labelled
cells towards the DiI labelled cells was observed (Fig. 6B-
B"). As the presumptive joint region is not clearly defined
morphologically, in some cases, a few cells in the pre-
sumptive incus were also labelled at the same time as the
joint. In these cases labelled cells could be seen incorpo-
rated into the developing incus (see Fig. 6B"). Although
cells did not appear to migrate from the presumptive joint
into the malleus, the joint region itself did change shape
and elongated caudally as the ossicles developed. This
does not necessarily represent active migration but a re-
shaping of the joint region as it is squeezed by the prolif-
erating ossicles on either side.
Downregulation of cartilage markers
From the lack of apoptosis or migration out of the form-
ing joint region it would appear that cells in the joint are
turning off a cartilage pathway and turning on a joint spe-
cific pathway. To test this we used Type II collagen reporter
mice (where LacZ is inserted into one copy of the Type II
collagen gene) to take advantage of the fact that the LacZ
protein is very stable. At E14.5 Type II collagen expression,
as assessed by in situ hybridisation or immunohistochem-
istry, is not observed in the joint region (Fig. 7A). Instead
joint markers, such as Gdf5, are expressed at high levels
throughout the joint (Fig. 7B) [1,10]. In contrast, blue
cells are still found at high levels in between the two ossi-
cles when the Type II collagen lacZ reporter mouse is
stained for LacZ at this stage (Fig. 7C). By combining a
LacZ stain (blue) and Type II collagen immunohisto-
chemistry (brown), cells that still express Type II collagen
will be visualised as both brown and blue, while those
cells that have recently turned off Type II collagen will be
blue only. We can thus view the expression history of cells
in the joint region.
Cells in the joint region at E14.5 expressed LacZ (blue),
while the surrounding ossicles expressed both LacZ (blue)
and the Type II collagen protein (brown) (Fig. 7D,E).
Thus the Type II collagen expressing cells have remained
in the same position and downregulated expression of
chondrogenic genes.
Loss of Caspases 3, 9 or Apaf-1 has no effect on the formation of the incudomalleal joint at E15.5Figure 3
Loss of Caspases 3, 9 or Apaf-1 has no effect on the formation of the incudomalleal joint at E15.5. Sagittal sections 
of middle ears stained with hematoxylin and eosin at E15.5. (A) The middle ear ossicles in the wildtype. (B) The middle ear oss-
icles in the Apaf-1 mutant. No defect in the initiation of the joint is observed. (C) The middle ear ossicles in the Caspase 3 
mutant. No defect in the initiation of the joint is observed. (D) TUNEL staining between the middle ear ossicles in a wildtype. 
(E) TUNEL staining of the middle ear ossicles in an Apaf-1 heterozygote. Positive cells are found in between the two ossicles as 
in the wildtype. (F) TUNEL staining of the middle ear ossicles in an Apaf-1 homozygote mutant. The area is negative for TUNEL 
positive cells. M = malleus and I = incus. Scale bar in (A) = 200 µm. Scale bar in (D) = 100 µm.Page 7 of 12
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Apoptosis has been described as a sculptor of develop-
ment in many mammalian structures and is observed in
developing limb joints [16-20]. Thus it seems a good can-
didate process for removal of Sox9/Type II collagen express-
ing cells to create a joint, and thereby separate the malleus
and incus. Apoptotic cells were observed early on between
the malleus and incus, however, Apaf-1, Caspase 3 and
Caspase 9 mutant mice exhibited normal division of the
malleus and incus at E15.5. No middle ear defect was also
observed in Apaf-1 mutants at E17.5. This is despite the
loss of TUNEL positive cells in the mutant. This result was
confirmed in explant culture by using caspase inhibitors.
Thus formation of the middle ear joint appears independ-
Joint formation appears normal at E17.5 in Apaf-1 mutantsFigure 4
Joint formation appears normal at E17.5 in Apaf-1 mutants. (A) Trichrome stained section of incudomalleal joint at 
E17.5 in an Apaf-1 wildtype littermate. (B) Trichrome stained section of incudomalleal joint at E17.5 in an Apaf-1 homozygote 
mutant. (C) Skeletal preparation with alcian blue staining of Apaf-1 wildtype littermate. (D) Skeletal preparation with alcian blue 
staining of Apaf-1 homozygous mutant. No defect in shaping of the articulation is observed. M = malleus. I = Incus. Scale bar in 
(A) = 200 µm. Scale bar in (C) = 400 µm.Page 8 of 12
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Inhibition of caspases has no effect on the formation of the incudomalleal jointFigure 5
Inhibition of caspases has no effect on the formation of the incudomalleal joint. (A) Limb grown for 24 hours in 1% 
DMSO control medium. (B) Limb grown for 24 hours with Z-VAD-FMK caspase inhibitor. Arrows in (B) point to interdigit 
webbing in the limbs treated with inhibitor. (C) Middle ear culture grown for three days with Z-VAD-FMK. Arrow points to 
the incudomalleal joint. M = malleus and I = incus. Scale bar (C) = 200 µm.
Cells do not migrate into the malleus from the developing incudomalleal jointFigure 6
Cells do not migrate into the malleus from the developing incudomalleal joint. Middle ear cultures labelled with DiI 
in the malleus (seen as orange) and DiO in the presumptive joint region (seen as blue). (A, B) Bright field. (A', A", B', B") Dark 
field image. (A-A") Culture 1 hour after labelling, showing distinct DiI and DiO dots. (A, A') Light and dark field images, same 
magnification. Arrows in (A) point to the DiI and DiO spots. (B-B") Same culture 2 days after labelling. The malleus and incus 
are now distinct, with the DiO label located in the joint region. No spread of the DiO labelled joint cells towards the DiI 
labelled malleus is observed. The DiO label has extended caudally, however, as the joint extends in this direction. (B, B') Light 
and dark field images, same magnification. Arrows in (B) point to the DiI and DiO spots. Malleus and incus are outlined by 
white dashes in (A" & B"). Scale bar in (A) = 300 µm. Scale bar in (A") = 100 µm.
BMC Developmental Biology 2007, 7:134 http://www.biomedcentral.com/1471-213X/7/134ent of apoptosis. It may be, however, that loss of apopto-
sis is compensated for by cell death through other
processes, such as necrosis or caspase independent pro-
grammed cell death, such as paraptosis [48]. Paraptosis,
like apoptosis, is programmed cell death but is independ-
ent of the normal apoptotic machinery [49]. In the limbs
of Apaf-1 mutants interdigital cell death is initially inhib-
ited but after a delay of a few days, cell death in these
regions is observed, resulting in separation of the digits.
This interdigital cell death occurs despite no evidence of
TUNEL positive cells or overall cell condensation [50].
Thus in the absence of apoptosis, as indicated by TUNEL
staining, cells may still be able to die.
Migration is another candidate process that could explain
the disappearance of cartilaginous presumptive joint cells.
DiI and DiO double labelling was used to trace the move-
ment of cells in the presumptive joint region over 2 days.
Results show that although the joint region changes
shape, the labelled cells in the joint region did not move
towards the DiI labelled cells and were not incorporated
into the malleus. This is perhaps unsurprising as chondro-
genic precursors have been shown to have a low migration
capacity when compared to many other cells types, such
as myogenic precursors [51].
By comparing the expression of Type II collagen protein
and a LacZ reporter driven by the same promoter, we have
shown that the initially chondrogenic cells remain in the
incudomalleal joint region and downregulate expression
of chondrogenic markers. In this way Type II collagen is
turned off and joint markers, such as Gdf5, are turned on
in the same cells. The signal to trigger this event is as yet
unknown. It is thus unclear how cells only in the pre-
sumptive joint region turn off Type II collagen, while those
on either side carry on with a cartilage differentiation
pathway. The homeobox gene Emx2 may play a role in
demarcating the future joint as it is expressed in the incus
Downregulation of cartilage fate in the incudomalleal regionFigure 7
Downregulation of cartilage fate in the incudomalleal region. (A) Collagen type II immunohistochemistry of the mid-
dle ear ossicles at E14.5. The ossicles appear positive (brown) while the presumptive joint is negative by this stage. (B) In situ 
hybridisation showing the expression of Gdf5 in the joint region of the middle ear at E14.5. (C) Dissected middle ear ossicles 
after wholemount staining for LacZ at E14.5. Strong expression of LacZ is visible in between the ossicles, which appear united 
(arrow). (D, E) Type II collagen lacZ reporter mouse. Collagen type II immunohistochemistry of the middle ear at E14.5 
(brown) and lacZ staining (blue). β gal positive cells are present in the joint region and ossicles, while the Type II collagen pro-
tein is only present in the ossicles. Arrows point to joint region. Scale bar in (A) = 100 µm. Scale bars in (C) = 175 µm. Scale 
bar in (D) = 200 µm. Scale bar in (E) = 70 µm. M = malleus. I = incus.Page 10 of 12
(page number not for citation purposes)
BMC Developmental Biology 2007, 7:134 http://www.biomedcentral.com/1471-213X/7/134and presumptive joint but excluded from the malleus,
prior to the separation of these two ossicles [1]. In keeping
with this role, mutations in Emx2 lead to loss of both the
incus and joint [52]. Joint markers, such as Bapx1 and
Gdf5, have been shown to turn on before loss of Sox9 and
Type II collagen [1]. It is possible, therefore, that these joint
markers act by directly repressing cartilage development.
Overexpression of Gdf5, however, is unable to induce for-
mation of an ectopic joint, thus although this gene has an
important role in joint formation it is not sufficient to
repress cartilage development [53,54]. In contrast, overex-
pression of Wnt signalling is sufficient to induce an
ectopic joint [55]. The role of Wnt signalling in formation
of the incudomalleal joint and its relationship to the loss
of cartilage markers is thus an interesting avenue to pur-
sue. What leads to the induction of joint markers at the
future incudo-malleal joint is also unclear. In the chick
and zebrafish, Bapx1 acts upstream of Gdf5 in develop-
ment of the primary jaw joint, with the expression of
Bapx1 being controlled by a combination of inhibitory
and inducing signals from Fgfs, Bmps and Endothelin
[8,9]. Whether a similar combination of signals leads to
the restriction of joint markers in the mammalian middle
ear is therefore another important area for future study.
Such comparative work will allow for further understand-
ing of how cranial joints are initiated and positioned and
will focus in on the genetic pathways that may have
played a role in changing the pattern of joints during evo-
lution.
Conclusion
The incudomalleal joint in the mammalian middle ear
separates the initially united incus and malleus. The form-
ing joint is characterised by a lack of proliferation, com-
pared to the ossicles on either side, and contains a number
of cells undergoing cell death (apoptosis). In the absence
of apoptosis, however, no defect in joint formation is
observed. Cells in the joint region do not move away from
this position but instead downregulate cartilage markers
and take on a joint fate, expressing genes such as Gdf5.
Fusions of the middle ear, as seen in patients with BOR
Syndrome or Treacher Collins Syndrome, may therefore
occur if presumptive joint cells fail to downregulate
expression of chondrogenic genes. Many of the genes
underlying such syndromes have been discovered, and so
the next challenge is to investigate such possibilities using
mouse models.
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